This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks to Watch: Apple, Foot Locker

Marvell Technology (MRVL):

The Santa Clara, Calif.-based chip maker reported adjusted earnings of $142 million, or 24 cents a share, in its fiscal second quarter on revenue of $816.1 million, missing the average estimate of analysts polled by Thomson Reuters for a profit of 26 cents a share on revenue of $852.7 million.

Marvell said its performance was held back by the weak macro-economic environment, which hurt its storage and mobile end markets.

Shares of Marvell closed Thursday at $12.28, and fell nearly 9% in after-hours action.

J.M. Smucker (SJM - Get Report):

The Orrville, Ohio-based food products company reported adjusted earnings of $129.3 million, or $1.17 a share, for its fiscal first quarter ended in July on revenue of $1.37 billion. The average estimate of analysts polled by Thomson Reuters was for a profit of $1 per share on revenue of $1.30 billion.

"We are pleased with the solid start to the fiscal year with growth in volume, sales, and cash flow," said Richard Smucker, the company's CEO, in a press release. "While the environment remains challenging, we continue to drive long-term growth through brand-building, product innovation, acquisitions, and productivity initiatives while maintaining a healthy balance between volume, market share, and profitability. Our results demonstrate the strength and resiliency of our iconic brands, our ability to adjust rapidly in the marketplace, and the commitment of our team to our strategy."

For fiscal 2013, J.M. Smucker backed its forecast for non-GAAP earnings of $5 to $5.10 a share with sales expected to rise 7%, and said it sees earnings at the top end of its projected range based on current expectations.

Walgreens (WAG):

Morgan Stanley upgraded the drugstore operator to equal-weight from underweight and removed its $31 price target.

"Express Scripts overhang removed, but risks remain: The resolution of the Express Scripts dispute removes the risk of further script losses and opens the door for Walgreens to start winning back lost customers," the firm said. "However, investors must now contemplate 1) the level of couponing required to lure back customers; 2) lingering front-end weakness from lost Express customer traffic; 3) margins under the new Express-Medco contract; and 4) risk that the Express-related cost cutting may have affected service levels for other customers."

The stock closed Thursday at $35.52, up more than 3% in the past year.

-- Written by Michael Baron in New York.

>To contact the writer of this article, click here: Michael Baron.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WAG $81.65 2.05%
AAPL $95.03 0.21%
BRCD $9.86 0.00%
FL $61.47 0.00%
SJM $127.78 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs